BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32983633)

  • 1. A prognostic long non-coding RNA-associated competing endogenous RNA network in head and neck squamous cell carcinoma.
    Zhang C; Cao W; Wang J; Liu J; Liu J; Wu H; Li S; Zhang C
    PeerJ; 2020; 8():e9701. PubMed ID: 32983633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
    Pan Y; Liu G; Wang D; Li Y
    Front Pharmacol; 2019; 10():150. PubMed ID: 30886579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
    Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W
    Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma.
    Ju Q; Zhao YJ; Ma S; Li XM; Zhang H; Zhang SQ; Yang YM; Yan SX
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1711-1723. PubMed ID: 32356177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Long Non-Coding RNAs and MicroRNAs Mediate the Endogenous RNA Network of Head and Neck Squamous Cell Carcinoma: a Comprehensive Analysis.
    Zhao G; Fu Y; Su Z; Wu R
    Cell Physiol Biochem; 2018; 50(1):332-341. PubMed ID: 30282065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of lncRNA-associated ceRNA network in p16-positive and p16-negative head and neck squamous cell carcinoma.
    Yang Y; Feng L; Wang R; Ma H; He S; Fang J
    Medicine (Baltimore); 2022 Aug; 101(33):e26120. PubMed ID: 35984201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic lncRNAs, miRNAs, and mRNAs Form a Competing Endogenous RNA Network in Colon Cancer.
    Huang QR; Pan XB
    Front Oncol; 2019; 9():712. PubMed ID: 31448228
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma.
    Wang J; Zhang C; He W; Gou X
    J Cell Biochem; 2019 Feb; 120(2):2576-2593. PubMed ID: 30278113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coding RNA Identification in Osteonecrosis of the Femoral Head Using Competitive Endogenous RNA Network Analysis.
    Han N; Li Z
    Orthop Surg; 2021 May; 13(3):1067-1076. PubMed ID: 33749138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma.
    Wang J; Zhang C; Wu Y; He W; Gou X
    Cancer Cell Int; 2019; 19():327. PubMed ID: 31827401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
    Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
    Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
    Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
    Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer.
    Lyu L; Xiang W; Zhu JY; Huang T; Yuan JD; Zhang CH
    Cancer Manag Res; 2019; 11():6061-6077. PubMed ID: 31308745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.